Skip to content

LISATA THERAPEUTICS, INC.: 10-Q filed 2016-11-07

What LISATA THERAPEUTICS, INC. reported in its quarterly report filed 2016-11-07 (fiscal Q3 2016): 42 published measures, 118 facts as tagged in accession 0000320017-16-000162.

This filing

Form
10-Q (quarterly report)
Filed
2016-11-07
Fiscal period
fiscal Q3 2016
Accession
0000320017-16-000162 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LISATA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-09-3057,278,938USD
At 2015-12-3157,205,295USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-09-3027,889,443USD
At 2015-12-3133,921,471USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-09-3010,745,990USD
At 2015-12-3123,713,533USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-09-3018,606,743USD
At 2015-12-3120,318,411USD
At 2015-09-3024,042,699USD
At 2014-12-3119,174,061USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-01-01 to 2016-09-30-20,292,230USD274
2015-01-01 to 2015-09-30-30,530,623USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-01-01 to 2016-09-302,315,753USD274
2015-01-01 to 2015-09-302,573,784USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-07-01 to 2016-09-309,317,473USD92
2016-01-01 to 2016-09-3025,107,391USD274
2015-07-01 to 2015-09-305,888,450USD92
2015-01-01 to 2015-09-3014,927,691USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-01-01 to 2016-09-3020,896,315USD274
2015-01-01 to 2015-09-3036,320,417USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2016-01-01 to 2016-09-30-2,315,753USD274
2015-01-01 to 2015-09-30-921,156USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-09-30-398,830,656USD
At 2015-12-31-372,132,490USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-07-01 to 2016-09-3046,954USD92
2016-01-01 to 2016-09-30147,286USD274
2015-07-01 to 2015-09-3046,633USD92
2015-01-01 to 2015-09-30-3,610,097USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-09-3017,123,693USD
At 2015-12-3117,064,900USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-6,860,853USD92
2016-01-01 to 2016-09-30-25,419,090USD274
2015-07-01 to 2015-09-30-10,383,008USD92
2015-01-01 to 2015-09-30-54,139,823USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-09-3029,964,763USD
At 2015-12-3129,272,432USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-07-01 to 2016-09-30384,915USD92
2016-01-01 to 2016-09-301,671,457USD274
2015-07-01 to 2015-09-30552,983USD92
2015-01-01 to 2015-09-301,651,222USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-09-3018,553,232USD
At 2015-12-3121,015,223USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-09-303,245,779USD
At 2015-12-314,107,388USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2016-09-307,013,315USD
At 2015-12-317,013,315USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2016-09-302,450,400USD
At 2016-06-302,450,400USD
At 2015-12-312,877,900USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-09-304,274,800USD
At 2015-12-312,566,101USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-07-01 to 2016-09-3016,178,326USD92
2016-01-01 to 2016-09-3050,526,481USD274
2015-07-01 to 2015-09-3016,271,458USD92
2015-01-01 to 2015-09-3069,067,514USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2016-07-01 to 2016-09-308,611,208USD92
2016-01-01 to 2016-09-3021,891,010USD274
2015-07-01 to 2015-09-304,808,679USD92
2015-01-01 to 2015-09-3013,976,087USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2016-07-01 to 2016-09-304,936,486USD92
2016-01-01 to 2016-09-3016,100,696USD274
2015-07-01 to 2015-09-305,147,166USD92
2015-01-01 to 2015-09-3024,971,438USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-07-01 to 2016-09-302,630,632USD92
2016-01-01 to 2016-09-3012,534,775USD274
2015-07-01 to 2015-09-306,315,613USD92
2015-01-01 to 2015-09-3020,719,989USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-09-308,181,921shares
At 2015-12-315,673,302shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-09-30410,276,001USD
At 2015-12-31396,547,401USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2016-09-309,989,495USD
At 2015-12-3123,283,824USD
At 2015-09-3054,996,419USD
At 2014-12-3158,073,789USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2016-06-306,700,000USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2016-09-302,450,380USD
At 2015-12-312,877,880USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-09-30726,787USD
At 2015-12-31976,768USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-09-30370,081USD
At 2015-12-31562,001USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-09-306,372,789USD
At 2015-12-316,198,488USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-09-302,767,243USD
At 2015-12-313,476,177USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-7,240,651USD92
2016-01-01 to 2016-09-30-27,072,885USD274
2015-07-01 to 2015-09-30-11,346,224USD92
2015-01-01 to 2015-09-30-51,392,460USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-7,287,605USD92
2016-01-01 to 2016-09-30-27,220,171USD274
2015-07-01 to 2015-09-30-11,392,857USD92
2015-01-01 to 2015-09-30-47,782,363USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-6,882,533USD92
2016-01-01 to 2016-09-30-26,698,652USD274
2015-07-01 to 2015-09-30-11,376,937USD92
2015-01-01 to 2015-09-30-47,689,557USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-6,882,533USD92
2016-01-01 to 2016-09-30-26,698,166USD274
2015-07-01 to 2015-09-30-11,375,950USD92
2015-01-01 to 2015-09-30-47,689,106USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2016-04-01 to 2016-06-30142,500USD91
2016-01-01 to 2016-06-30427,500USD182
2015-04-01 to 2015-06-30151,300USD91
2015-01-01 to 2015-06-30453,900USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-07-01 to 2016-09-305,117USD92
2016-01-01 to 2016-09-3017,662USD274
2015-07-01 to 2015-09-30-410,233USD92
2015-01-01 to 2015-09-304,398,585USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-379,798USD92
2016-01-01 to 2016-09-30-1,653,795USD274
2015-07-01 to 2015-09-30-963,216USD92
2015-01-01 to 2015-09-302,747,363USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-09-301,708,699USD274
2015-01-01 to 2015-09-30-815,231USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-09-301,404,234USD274
2015-01-01 to 2015-09-30781,629USD273

Inspect the source

Entity
LISATA THERAPEUTICS, INC. / CIK 0000320017
Captured
2026-09-19T14:56:51.274Z
SEC response SHA-256
cea21c045f03a86f28b8ca2c2ed8647182755ec7b9afe40200702f5307c095db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000320017.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))